Literature DB >> 27856216

Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host.

Ada W C Yan1, Pengxing Cao1, Jane M Heffernan2, Jodie McVernon3, Kylie M Quinn4, Nicole L La Gruta4, Karen L Laurie5, James M McCaw6.   

Abstract

The cellular adaptive immune response plays a key role in resolving influenza infection. Experiments where individuals are successively infected with different strains within a short timeframe provide insight into the underlying viral dynamics and the role of a cross-reactive immune response in resolving an acute infection. We construct a mathematical model of within-host influenza viral dynamics including three possible factors which determine the strength of the cross-reactive cellular adaptive immune response: the initial naive T cell number, the avidity of the interaction between T cells and the epitopes presented by infected cells, and the epitope abundance per infected cell. Our model explains the experimentally observed shortening of a second infection when cross-reactivity is present, and shows that memory in the cellular adaptive immune response is necessary to protect against a second infection. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxic T lymphocyte; Immunology; Mathematical model; Viral dynamics

Mesh:

Substances:

Year:  2016        PMID: 27856216     DOI: 10.1016/j.jtbi.2016.11.008

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  10 in total

1.  Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Authors:  Karen L Laurie; William Horman; Louise A Carolan; Kok Fei Chan; Daniel Layton; Andrew Bean; Dhanasekaran Vijaykrishna; Patrick C Reading; James M McCaw; Ian G Barr
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

Review 2.  Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.

Authors:  Lulla Opatowski; Marc Baguelin; Rosalind M Eggo
Journal:  PLoS Pathog       Date:  2018-02-15       Impact factor: 6.823

Review 3.  Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling.

Authors:  Amber M Smith
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

4.  Investigating Different Mechanisms of Action in Combination Therapy for Influenza.

Authors:  Kelli Melville; Thalia Rodriguez; Hana M Dobrovolny
Journal:  Front Pharmacol       Date:  2018-10-23       Impact factor: 5.810

5.  Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection.

Authors:  Ada W C Yan; Sophie G Zaloumis; Julie A Simpson; James M McCaw
Journal:  PLoS Comput Biol       Date:  2019-01-17       Impact factor: 4.475

6.  Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine.

Authors:  Xuejie Liu; Tianyi Zhao; Liangliang Wang; Minchao Li; Caijun Sun; Yuelong Shu
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

7.  Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.

Authors:  Ke Li; Pengxing Cao; James M McCaw
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

Review 8.  Data-driven methods for present and future pandemics: Monitoring, modelling and managing.

Authors:  Teodoro Alamo; Daniel G Reina; Pablo Millán Gata; Victor M Preciado; Giulia Giordano
Journal:  Annu Rev Control       Date:  2021-06-29       Impact factor: 6.091

9.  Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.

Authors:  Kok Fei Chan; Louise A Carolan; Daniil Korenkov; Julian Druce; James McCaw; Patrick C Reading; Ian G Barr; Karen L Laurie
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

10.  Evaluation of the Pathogenicity and the Escape from Vaccine Protection of a New Antigenic Variant Derived from the European Human-Like Reassortant Swine H1N2 Influenza Virus.

Authors:  Céline Deblanc; Stéphane Quéguiner; Stéphane Gorin; Amélie Chastagner; Séverine Hervé; Frédéric Paboeuf; Gaëlle Simon
Journal:  Viruses       Date:  2020-10-12       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.